A Phase 1 Study of LNCB74 in Advanced Solid Tumors
This is an open-label, phase 1, dose escalation and dose expansion study to determine safety and tolerability, and to determine the maximum tolerated dose and / or recommended phase 2 dose of LNCB74 in participants with advanced solid tumors.
The participant provides written informed consent [+10]
A WOCBP who has a positive serum pregnancy test (within 72 hours) prior to treat... [+29]